What looks to be a small wine fridge is tucked away inconspicuously in the corner of Veradigm’s 12th floor office in the Flatiron neighborhood of Manhattan. But rather than bottles of burgundy, the ...
VICTORIA, Texas (AP) — A federal judge in Texas on Friday upheld a key piece of President Joe Biden’s immigration policy that allows a limited number of migrants from four countries to enter the U.S.
QuantHealth, an Israeli AI-enabled clinical trial-design startup, announced that David Dornstreich is joining the company as its general manager and chief commercial officer of U.S. operations, which ...
Microsoft is extending the Startup Founders Hub, its self-service platform that provides founders with free resources including Azure credits, with a new incubator program called the Pegasus Program.
Security settings on Windows PCs often have admin rights enabled by default. It makes sense since most normal users shouldn’t need admin rights. However, many standard Windows users will come across ...
Allscripts Healthcare Solutions announced on Tuesday that the company will now be called Veradigm. In March 2022 the electronic health record vendor – which was founded in 1986 and grew through many ...
In a report released on November 30, Stephanie Davis from SVB Securities reiterated a Buy rating on Allscripts (MDRX - Research Report), with a price target of $24.00. The companys shares closed ...
Allscripts Healthcare Solutions, Inc. MDRX delivered adjusted earnings per share (EPS) of 23 cents in the third quarter of 2022, up 9.5% year over year. The figure topped the Zacks Consensus Estimate ...
Allscripts Healthcare Solutions, Inc. MDRX is well-poised for growth in the coming quarters, courtesy of its strategic alliances over the past few months. A robust second-quarter 2022 performance and ...
Allscripts Healthcare Solutions, Inc. MDRX delivered adjusted earnings per share (EPS) of 18 cents in the second quarter of 2022, flat year over year. The figure, however, topped the Zacks Consensus ...
Allscripts Healthcare Solutions on Thursday posted a nearly 7% rise in year-over-year second-quarter revenue as it continues to refocus its business on its payer and life sciences division, Veradigm.
UPDATE: This news item has been edited to remove the reference to WoundZoom’s work with Cerner. The news was premature, as the technology is self-certified and still working on validation through ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results